Dennis Mewis

Title: Dennis Mewis: Innovator in Radiopharmaceuticals

Introduction

Dennis Mewis is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of radiopharmaceuticals, holding 2 patents that showcase his innovative spirit and dedication to medical advancements.

Latest Patents

Mewis's latest patents include a radiopharmaceutical composition and methods. This invention relates to a liquid radiopharmaceutical composition comprising a radiopharmaceutical compound and a buffer, which provides the composition with a pH of about 7.0 to about 8.9. Additionally, he has developed a composition containing a somatostatin analogue for radiopharmaceutical use, particularly for diagnostic or therapeutic applications. This somatostatin analogue is a receptor-selective somatostatin peptide antagonist.

Career Highlights

Dennis Mewis is currently associated with Ariceum Therapeutics GmbH, where he continues to push the boundaries of medical research and innovation. His work focuses on developing advanced radiopharmaceuticals that can significantly improve diagnostic and therapeutic outcomes.

Collaborations

Mewis collaborates with talented professionals in his field, including Sabine Hovest and Anne Petit. Their combined expertise contributes to the success of their projects and the advancement of radiopharmaceutical technology.

Conclusion

Dennis Mewis stands out as an influential inventor in the realm of radiopharmaceuticals. His innovative patents and collaborative efforts are paving the way for future advancements in medical science.